Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

COVID-19 and its health consequences

21.02.2023
The cross-state health report for Berlin and Brandenburg

Read more

How digital are Berlin's businesses?

17.02.2023
New study by the Technologiestiftung Berlin

Read more

Berlin is knorke: the cheese of the future

30.01.2023
The biotech company Formo develops animal-free high-tech dairy products.

Read more

Diversity bei Berlin-Partnern gelebt

24.01.2023
The Berlin Partner network presented some of its best practices on the subject of diversity at the Berlin Partner New Year’s Talk.

Read more

Berlin Fashion Week 2023

16.01.2023
The fashion world is guest in Berlin from 16 to 21 January

Read more

Record month for new electric cars in Berlin

13.01.2023
In December, 52% of newly registered vehicles in Berlin were electric. This figure has doubled compared to the previous year.

Read more